What is scope of the report?

The base year for the study has been considered 2019, historic year 2014 and 2018. Read More

What are the significant segments operating in the market?

Market is segmented on the basis. Read More

What are the vital market dynamics?

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. Read More

What does a company profile includes?

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering. Read More

Global Particle Therapy Market by Type (Heavy Ion, Proton Therapy), Products, Services, System, Cancer Type, Application, Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2018 to 2025

Publish Date: Mar, 2019
Report ID: 376058
Category: Pharmaceutical
Pages: 0

$4700

Global particle therapy market is expected to reach USD 879.07 Million in 2017 to USD 2105.41 Million by 2025 at a CAGR of 11.37% from 2018 to 2025. The rising prevalence of cancer cases, high demand and increasing preference for advanced therapies in cancer treatment by physicians are contributing to the growth of the market.

Market Overview:

Particle therapy is a technique which uses rays of charged positive ions, neutrons, or protons for cancer treatment. It is external beam radiotherapy. It combines research in physics and its application in the field of oncology. The non-invasive characteristic of particle therapy serves as a major advantage for the treatment of cancer. Carbon ion beams are used in the treatment of cancer. Proton therapy is one of the most used types of particle therapy. It uses proton beams to irradiate affected tissue. Proton therapy employs ionizing radiation, in which a particle accelerator is used to aim tumors with proton beams.

Report Description:

The base year for the study has been considered 2017, the historic year 2015 and 2016 and, the forecast period considered is from 2018 to 2025. The Particle Therapy market is analyzed by value (USD Million).
The study delivers a comprehensive analysis of the global particle therapy market by type, products, services, system, cancer type, application, and regions.
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2018 to 2025.
Porter’s Five Forces model is used to recognize the competitive scenario in the global particle therapy market. This report incorporates the industry analysis which is focused on providing an extensive view of the Particle Therapy market.
The study also includes attractiveness analysis of type, products, services, system, cancer type, application, and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
The report provides company profile of the key players operating in the particle therapy market and a comparative analysis based on their business overviews, product offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

Market Dynamics:

Drivers:

Advantages provided by particle therapy over photon therapy
The growing prevalence of cancer worldwide
Growing adoption of particle therapy in clinical trials
The increasing number of particle therapy centers across the globe

Restraints:

Infrastructural restrictions in healthcare facilities
Unfavorable reimbursement policies and limited insurance coverage

Opportunities:

Growing adoption of pencil-beam scanning
Demand from emerging markets

Challenges:

Stringent regulations and the high cost of the procedure

Global Particle Therapy Market Key Findings:

All the segments have been analyzed on global, regional and country basis. The study includes an analysis of more than 30 countries for each segment.

Segmentation Analysis:

The Particle Therapy market is segmented by type, products, services, system, cancer type, application.

The type segment is classified into proton therapy and heavy ion therapy. The proton therapy segment was dominating the market and held the largest market share of 56.90% in 2017. The growth of the segment can be attributed to a high degree of precision, reduced side-effects and less treatment time as compared to conventional photon therapies using X-rays.
Product segment further segmented into cyclotrons, synchrotrons, synchrocyclotrons, and services. In which, synchrotrons are dominating the segment and is expected to grow with the highest CAGR of 13.07% in the forecast period. The growth of the segment is due to factors such as the increasing number of research activities and increasing investments in the development of synchrotron facilities.
System segment is classified into single-room and multi-room systems. The multi-room systems are dominating the segment and held the largest share of 56.37% in 2017. The single room center is equipped with only a single patient room, whereas multi-room center is equipped with multiple patient rooms so that more patients can be treated simultaneously.
The cancer type segment is divided into pediatric cancer, lung cancer, prostate cancer, head and neck cancer, and others. Lung cancer is dominating the segment due to healthcare professionals inclination towards particle therapy for lung cancer treatment.
Application segment includes treatment applications and research applications. Treatment applications were dominating the segment and were valued at around USD 518.61 million in 2017. Introduction of small single-room particle therapy centers for the treatment of cancer and the increasing availability of funding for the procedures are driving the growth of the segment.

Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. Asia Pacific region dominated the global particle therapy market with USD 430.71 Million in 2017 whereas North America held the second position in the forecast period.

The Asia Pacific dominated the market owing to increasing per capita income, developing healthcare infrastructure, and supportive government activities in developing countries are bolstering the growth in the region.
North America held the second largest share of the market. Rising geriatric population, the increasing number of cancer patients and rising acceptance of particle therapy procedures are contributing to the growth of the segment.

Global Particle Therapy Market Competitive Analysis:

Key players in the particle therapy market are Varian Medical Systems, Inc., Ion Beam Applications SA, Provision Healthcare, Hitachi, Ltd., Mevion Medical Systems, Inc., Optivus Proton Therapy, Inc., Sumitomo Heavy Industries, Ltd., Advanced Oncotherapy plc, Danfysik A/S, ProTom International, Inc., and others. Market participants are engaged in various strategies to increase their footprints in the market. For instance, in 2017, Mitsubishi Electric entered into an agreement to transfer its particle therapy systems business to Hitachi. This agreement intended to improve Hitachi’s position in the proton therapy market.

This study forecasts revenue at global, regional, and country levels from 2015 to 2025. Fior Market Research has segmented the global Particle Therapy market on the basis of below mentioned segments:

Global Particle Therapy Market, By Type:

Proton Therapy
Heavy Ion Therapy

Global Particle Therapy Market, By Product & Service:

Products
Cyclotrons
Synchrotrons
Synchrocyclotrons
Services

Global Particle Therapy Market, By System:

Multi-room Systems
Single-room Systems

Global Particle Therapy Market, By Cancer Type:

Pediatric Cancer
Prostate Cancer
Breast Cancer
Lung Cancer
Head and Neck Cancer
Other Cancers

Global Particle Therapy Market, By Application:

Treatment Applications
Research Applications

Global Particle Therapy Market, By Regions:

North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- France
- Sweden
- Netherlands
- U.K.
- Italy
- Spain
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- South Korea
- Australia
- Singapore
- Malaysia
- Thailand
- Indonesia
- Philippines
- Rest of Asia-Pacific
South America
- Brazil
- Argentina
- Colombia
- Rest of South America
The Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of The Middle East and Africa

*All our reports are customizable as per customer requirements

Request Sample Request for Customization

1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market attractiveness analysis by type
4.3.2. Market attractiveness analysis by products
4.3.3. Market attractiveness analysis by services
4.3.4. Market attractiveness analysis by system
4.3.5. Market attractiveness analysis by cancer type
4.3.6. Market attractiveness analysis by region
4.4. Industry Trends

5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Advantages provided by particle therapy over photon therapy
5.2.2. Growing prevalence of cancer worldwide
5.2.3. Growing adoption of particle therapy in clinical trials
5.2.4. Increasing number of particle therapy centers across the globe
5.3. Restraints
5.3.1. Infrastructural restrictions in healthcare facilities
5.3.2. Unfavourable reimbursement policies and limited insurance coverage
5.4. Opportunities
5.4.1. Growing adoption of pencil-beam scanning
5.4.2. Demand from emerging markets
5.5. Challenges
5.5.1. Stringent regulations and high cost of the procedure

6. Global Particle Therapy Market Analysis and Forecast, By Type
6.1. Segment Overview
6.2. Proton Therapy
6.3. Heavy Ion Therapy

7. Global Particle Therapy Market Analysis and Forecast, By Product & Service
7.1. Segment Overview
7.2. Products
7.2.1.1. Cyclotrons
7.2.1.2. Synchrotrons
7.2.1.3. Synchrocyclotrons
7.3. Services

8. Global Particle Therapy Market Analysis and Forecast, By System
8.1. Segment Overview
8.2. Multi-room Systems
8.3. Single-room Systems

9. Global Particle Therapy Market Analysis and Forecast, By Cancer Type
9.1. Segment Overview
9.2. Pediatric Cancer
9.3. Prostate Cancer
9.4. Breast Cancer
9.5. Lung Cancer
9.6. Head and Neck Cancer
9.7. Other Cancers

10. Global Particle Therapy Market Analysis and Forecast, By Cancer Type
10.1. Segment Overview
10.2. Treatment Cancer Types
10.3. Research Cancer Types

11. Global Particle Therapy Market Analysis and Forecast, By Regional Analysis
11.1. Segment Overview
11.2. North America
11.2.1. U.S.
11.2.2. Canada
11.2.3. Mexico
11.3. Europe
11.3.1. Germany
11.3.2. France
11.3.3. Sweden
11.3.4. Netherlands
11.3.5. U.K.
11.3.6. Italy
11.3.7. Spain
11.3.8. Turkey
11.3.9. Switzerland
11.3.10. Belgium
11.3.11. Rest of Europe
11.4. Asia-Pacific
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. South Korea
11.4.5. Australia
11.4.6. Singapore
11.4.7. Malaysia
11.4.8. Thailand
11.4.9. Indonesia
11.4.10. Philippines
11.4.11. Rest of Asia-Pacific
11.5. South America
11.5.1. Brazil
11.5.2. Argentina
11.5.3. Colombia
11.5.4. Rest of South America
11.6. Middle East and Africa
11.6.1. Saudi Arabia
11.6.2. UAE
11.6.3. Egypt
11.6.4. Nigeria
11.6.5. South Africa
11.6.6. Rest of Middle East and Africa

12. Global Particle Therapy Market-Competitive Landscape
12.1. Overview
12.2. Market Share of Key Players in the Particle Therapy Market
12.2.1. Global Company Market Share
12.2.2. North America Company Market Share
12.2.3. Europe Company Market Share
12.2.4. APAC Company Market Share
12.3. Competitive Situations and Trends
12.3.1. Product Launches and Developments
12.3.2. Partnerships, Collaborations, and Agreements
12.3.3. Mergers & Acquisitions
12.3.4. Expansions

13. Company Profiles
13.1. Varian Medical Systems, Inc
13.1.1. Business Overview
13.1.2. Company Snapshot
13.1.3. Company Market Share Analysis
13.1.4. Company Product Portfolio
13.1.5. Recent Developments
13.1.6. SWOT Analysis
13.2. Ion Beam Cancer Types SA
13.2.1. Business Overview
13.2.2. Company Snapshot
13.2.3. Company Market Share Analysis
13.2.4. Company Product Portfolio
13.2.5. Recent Developments
13.2.6. SWOT Analysis
13.3. Provision Healthcare
13.3.1. Business Overview
13.3.2. Company Snapshot
13.3.3. Company Market Share Analysis
13.3.4. Company Product Portfolio
13.3.5. Recent Developments
13.3.6. SWOT Analysis
13.4. Hitachi, Ltd
13.4.1. Business Overview
13.4.2. Company Snapshot
13.4.3. Company Market Share Analysis
13.4.4. Company Product Portfolio
13.4.5. Recent Developments
13.4.6. SWOT Analysis
13.5. Mevion Medical Systems, Inc.
13.5.1. Business Overview
13.5.2. Company Snapshot
13.5.3. Company Market Share Analysis
13.5.4. Company Product Portfolio
13.5.5. Recent Developments
13.5.6. SWOT Analysis
13.6. Optivus Proton Therapy, Inc.
13.6.1. Business Overview
13.6.2. Company Snapshot
13.6.3. Company Market Share Analysis
13.6.4. Company Product Portfolio
13.6.5. Recent Developments
13.6.6. SWOT Analysis
13.7. Sumitomo Heavy Industries, Ltd
13.7.1. Business Overview
13.7.2. Company Snapshot
13.7.3. Company Market Share Analysis
13.7.4. Company Product Portfolio
13.7.5. Recent Developments
13.7.6. SWOT Analysis
13.8. Advanced Oncotherapy plc
13.8.1. Business Overview
13.8.2. Company Snapshot
13.8.3. Company Market Share Analysis
13.8.4. Company Product Portfolio
13.8.5. Recent Developments
13.8.6. SWOT Analysis
13.9. Danfysik A/S
13.9.1. Business Overview
13.9.2. Company Snapshot
13.9.3. Company Market Share Analysis
13.9.4. Company Product Portfolio
13.9.5. Recent Developments
13.9.6. SWOT Analysis
13.10. ProTom International
13.10.1. Business Overview
13.10.2. Company Snapshot
13.10.3. Company Market Share Analysis
13.10.4. Company Product Portfolio
13.10.5. Recent Developments
13.10.6. SWOT Analysis
13.11. Mitsubishi Electric
13.11.1. Business Overview
13.11.2. Company Snapshot
13.11.3. Company Market Share Analysis
13.11.4. Company Product Portfolio
13.11.5. Recent Developments
13.11.6. SWOT Analysis
13.12. Fermilab Scientists
13.12.1. Business Overview
13.12.2. Company Snapshot
13.12.3. Company Market Share Analysis
13.12.4. Company Product Portfolio
13.12.5. Recent Developments
13.12.6. SWOT Analysis
13.13. Mevion Medical Systems, Inc.
13.13.1. Business Overview
13.13.2. Company Snapshot
13.13.3. Company Market Share Analysis
13.13.4. Company Product Portfolio
13.13.5. Recent Developments
13.13.6. SWOT Analysis
13.14. IBA Worldwide
13.14.1. Business Overview
13.14.2. Company Snapshot
13.14.3. Company Market Share Analysis
13.14.4. Company Product Portfolio
13.14.5. Recent Developments
13.14.6. SWOT Analysis

List of Table
1. Global Particle Therapy Market, By Type, 2015–2025 (USD Million)
2. Global Heavy Ion Therapy Particle Therapy Market, By Region, 2015–2025 (USD Million
3. Global Particle Therapy Market, By Product & Service, 2015–2025 (USD Million)
4. Global Products Particle Therapy Market, By Region, 2015–2025 (USD Million)
5. Global Services Particle Therapy Market, By Region, 2015–2025 (USD Million)
6. Global Particle Therapy Market, BY System, 2015–2025 (USD Million)
7. Global Multi-room Systems Particle Therapy Market, By Region, 2015–2025 (USD Million)
8. Global Single-room Systems Particle Therapy Market, By Region, 2015–2025 (USD Million)
9. Global Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
10. Global Pediatric Cancer Particle Therapy Market, By Region, 2015–2025 (USD Million)
11. Global Prostate Cancer Particle Therapy Market, By Region, 2015–2025 (USD Million)
12. Global Breast Cancer Particle Therapy Market, By Region, 2015–2025 (USD Million)
13. Global Lung Cancer Particle Therapy Market, By Region, 2015–2025 (USD Million)
14. Global others Particle Therapy Market, By Region, 2015–2025 (USD Million)
15. Global Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
16. Global Treatment Cancer Types Particle Therapy Market, By Region, 2015–2025 (USD Million)
17. Global Research Cancer Types Particle Therapy Market, By Region, 2015–2025 (USD Million)
18. Global Particle Therapy Market, By Region, 2015–2025 (USD Million)
19. North America Particle Therapy Market, By Type, 2015–2025 (USD Million)
20. North America Particle Therapy Market, By Product, 2015–2025 (USD Million)
21. North America Particle Therapy Market, By Services 2015–2025 (USD Million)
22. North America Particle Therapy Market, By System 2015–2025 (USD Million)
23. North America Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
24. North America Particle Therapy Market, By Application, 2015–2025 (USD Million)
25. U.S. Particle Therapy Market, By Type, 2015–2025 (USD Million)
26. U.S. Particle Therapy Market, By Product, 2015–2025 (USD Million)
27. U.S. Particle Therapy Market, By Services 2015–2025 (USD Million)
28. U.S. Particle Therapy Market, By System 2015–2025 (USD Million)
29. U.S. Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
30. U.S. Particle Therapy Market, By Application, 2015–2025 (USD Million)
31. Canada Particle Therapy Market, By Type, 2015–2025 (USD Million)
32. Canada Particle Therapy Market, By Product, 2015–2025 (USD Million)
33. Canada Particle Therapy Market, By Services 2015–2025 (USD Million)
34. Canada Particle Therapy Market, By System 2015–2025 (USD Million)
35. Canada Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
36. Canada Particle Therapy Market, By Application, 2015–2025 (USD Million)
37. Mexico Particle Therapy Market, By Type, 2015–2025 (USD Million)
38. Mexico Particle Therapy Market, By Product, 2015–2025 (USD Million)
39. Mexico Particle Therapy Market, By Services 2015–2025 (USD Million)
40. Mexico Particle Therapy Market, By System 2015–2025 (USD Million)
41. Mexico Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
42. Mexico Particle Therapy Market, By Application, 2015–2025 (USD Million)
43. Europe Particle Therapy Market, By Type, 2015–2025 (USD Million)
44. Europe Particle Therapy Market, By Product, 2015–2025 (USD Million)
45. Europe Particle Therapy Market, By Services 2015–2025 (USD Million)
46. Europe Particle Therapy Market, By System 2015–2025 (USD Million)
47. Europe Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
48. Europe Particle Therapy Market, By Application, 2015–2025 (USD Million)
49. Germany Particle Therapy Market, By Type, 2015–2025 (USD Million)
50. Germany Particle Therapy Market, By Product, 2015–2025 (USD Million)
51. Germany Particle Therapy Market, By Services 2015–2025 (USD Million)
52. Germany Particle Therapy Market, By System 2015–2025 (USD Million)
53. Germany Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
54. Germany Particle Therapy Market, By Application, 2015–2025 (USD Million)
55. France Particle Therapy Market, By Type, 2015–2025 (USD Million)
56. France Particle Therapy Market, By Product, 2015–2025 (USD Million)
57. France Particle Therapy Market, By Services 2015–2025 (USD Million)
58. France Particle Therapy Market, By System 2015–2025 (USD Million)
59. France Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
60. France Particle Therapy Market, By Application, 2015–2025 (USD Million)
61. Sweden Particle Therapy Market, By Type, 2015–2025 (USD Million)
62. Sweden Particle Therapy Market, By Product, 2015–2025 (USD Million)
63. Sweden Particle Therapy Market, By Services 2015–2025 (USD Million)
64. Sweden Particle Therapy Market, By System 2015–2025 (USD Million)
65. Sweden Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
66. Sweden Particle Therapy Market, By Application, 2015–2025 (USD Million)
67. Netherlands Particle Therapy Market, By Type, 2015–2025 (USD Million)
68. Netherlands Particle Therapy Market, By Product, 2015–2025 (USD Million)
69. Netherlands Particle Therapy Market, By Services 2015–2025 (USD Million)
70. Netherlands Particle Therapy Market, By System 2015–2025 (USD Million)
71. Netherlands Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
72. Netherlands Particle Therapy Market, By Application, 2015–2025 (USD Million)
73. U.K. Particle Therapy Market, By Type, 2015–2025 (USD Million)
74. U.K. Particle Therapy Market, By Product, 2015–2025 (USD Million)
75. U.K. Particle Therapy Market, By Services 2015–2025 (USD Million)
76. U.K. Particle Therapy Market, By System 2015–2025 (USD Million)
77. U.K. Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
78. U.K. Particle Therapy Market, By Application, 2015–2025 (USD Million)
79. Italy Particle Therapy Market, By Type, 2015–2025 (USD Million)
80. Italy Particle Therapy Market, By Product, 2015–2025 (USD Million)
81. Italy Particle Therapy Market, By Services 2015–2025 (USD Million)
82. Italy Particle Therapy Market, By System 2015–2025 (USD Million)
83. Italy Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
84. Italy Particle Therapy Market, By Application, 2015–2025 (USD Million)
85. Spain Particle Therapy Market, By Type, 2015–2025 (USD Million)
86. Spain Particle Therapy Market, By Product, 2015–2025 (USD Million)
87. Spain Particle Therapy Market, By Services 2015–2025 (USD Million)
88. Spain Particle Therapy Market, By System 2015–2025 (USD Million)
89. Spain Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
90. Spain Particle Therapy Market, By Application, 2015–2025 (USD Million)
91. Turkey Particle Therapy Market, By Type, 2015–2025 (USD Million)
92. Turkey Particle Therapy Market, By Product, 2015–2025 (USD Million)
93. Turkey Particle Therapy Market, By Services 2015–2025 (USD Million)
94. Turkey Particle Therapy Market, By System 2015–2025 (USD Million)
95. Turkey Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
96. Turkey Particle Therapy Market, By Application, 2015–2025 (USD Million)
97. Switzerland Particle Therapy Market, By Type, 2015–2025 (USD Million)
98. Switzerland Particle Therapy Market, By Product, 2015–2025 (USD Million)
99. Switzerland Particle Therapy Market, By Services 2015–2025 (USD Million)
100. Switzerland Particle Therapy Market, By System 2015–2025 (USD Million)
101. Switzerland Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
102. Switzerland Particle Therapy Market, By Application, 2015–2025 (USD Million)
103. Belgium Particle Therapy Market, By Type, 2015–2025 (USD Million)
104. Belgium Particle Therapy Market, By Product, 2015–2025 (USD Million)
105. Belgium Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
106. Belgium Particle Therapy Market, By Services 2015–2025 (USD Million)
107. Belgium Particle Therapy Market, By System 2015–2025 (USD Million)
108. Belgium Particle Therapy Market, By Application, 2015–2025 (USD Million)
109. Asia Pacific Particle Therapy Market, By Type, 2015–2025 (USD Million)
110. Asia Pacific Particle Therapy Market, By Product, 2015–2025 (USD Million)
111. Asia Pacific Particle Therapy Market, By Services 2015–2025 (USD Million)
112. Asia Pacific Particle Therapy Market, By System 2015–2025 (USD Million)
113. Asia Pacific Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
114. Asia Pacific Particle Therapy Market, By Application, 2015–2025 (USD Million)
115. Japan Particle Therapy Market, By Type, 2015–2025 (USD Million)
116. Japan Particle Therapy Market, By Product, 2015–2025 (USD Million)
117. Japan Particle Therapy Market, By Services 2015–2025 (USD Million)
118. Japan Particle Therapy Market, By System 2015–2025 (USD Million)
119. Japan Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
120. Japan Particle Therapy Market, By Application, 2015–2025 (USD Million)
121. China Particle Therapy Market, By Type, 2015–2025 (USD Million)
122. China Particle Therapy Market, By Product, 2015–2025 (USD Million)
123. China Particle Therapy Market, By Services 2015–2025 (USD Million)
124. China Particle Therapy Market, By System 2015–2025 (USD Million)
125. China Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
126. China Particle Therapy Market, By Application, 2015–2025 (USD Million)
127. India Particle Therapy Market, By Type, 2015–2025 (USD Million)
128. India Particle Therapy Market, By Product, 2015–2025 (USD Million)
129. India Particle Therapy Market, By Services 2015–2025 (USD Million)
130. India Particle Therapy Market, By System 2015–2025 (USD Million)
131. India Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
132. India Particle Therapy Market, By Application, 2015–2025 (USD Million)
133. South Korea Particle Therapy Market, By Type, 2015–2025 (USD Million)
134. South Korea Particle Therapy Market, By Product, 2015–2025 (USD Million)
135. South Korea Particle Therapy Market, By Services 2015–2025 (USD Million)
136. South Korea Particle Therapy Market, By System 2015–2025 (USD Million)
137. South Korea Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
138. South Korea Particle Therapy Market, By Application, 2015–2025 (USD Million)
139. Australia Particle Therapy Market, By Type, 2015–2025 (USD Million)
140. Australia Particle Therapy Market, By Product, 2015–2025 (USD Million)
141. Australia Particle Therapy Market, By Services 2015–2025 (USD Million)
142. Australia Particle Therapy Market, By System 2015–2025 (USD Million)
143. Australia Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
144. Australia Particle Therapy Market, By Application, 2015–2025 (USD Million)
145. Singapore Particle Therapy Market, By Type, 2015–2025 (USD Million)
146. Singapore Particle Therapy Market, By Product, 2015–2025 (USD Million)
147. Singapore Particle Therapy Market, By Services 2015–2025 (USD Million)
148. Singapore Particle Therapy Market, By System 2015–2025 (USD Million)
149. Singapore Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
150. Singapore Particle Therapy Market, By Application, 2015–2025 (USD Million)
151. Malaysia Particle Therapy Market, By Type, 2015–2025 (USD Million)
152. Malaysia Particle Therapy Market, By Product, 2015–2025 (USD Million)
153. Malaysia Particle Therapy Market, By Services 2015–2025 (USD Million)
154. Malaysia Particle Therapy Market, By System 2015–2025 (USD Million)
155. Malaysia Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
156. Malaysia Particle Therapy Market, By Application, 2015–2025 (USD Million)
157. Thailand Particle Therapy Market, By Type, 2015–2025 (USD Million)
158. Thailand Particle Therapy Market, By Product, 2015–2025 (USD Million)
159. Thailand Particle Therapy Market, By Services 2015–2025 (USD Million)
160. Thailand Particle Therapy Market, By System 2015–2025 (USD Million)
161. Thailand Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
162. Thailand Particle Therapy Market, By Application, 2015–2025 (USD Million)
163. Indonesia Particle Therapy Market, By Type, 2015–2025 (USD Million)
164. Indonesia Particle Therapy Market, By Product, 2015–2025 (USD Million)
165. Indonesia Particle Therapy Market, By Services 2015–2025 (USD Million)
166. Indonesia Particle Therapy Market, By System 2015–2025 (USD Million)
167. Indonesia Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
168. Indonesia Particle Therapy Market, By Application, 2015–2025 (USD Million)
169. Philippines Particle Therapy Market, By Type, 2015–2025 (USD Million)
170. Philippines Particle Therapy Market, By Product, 2015–2025 (USD Million)
171. Philippines Particle Therapy Market, By Services 2015–2025 (USD Million)
172. Philippines Particle Therapy Market, By System 2015–2025 (USD Million)
173. Philippines Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
174. Philippines Particle Therapy Market, By Application, 2015–2025 (USD Million)
175. South America Particle Therapy Market, By Type, 2015–2025 (USD Million)
176. South America Particle Therapy Market, By Product, 2015–2025 (USD Million)
177. South America Particle Therapy Market, By Services 2015–2025 (USD Million)
178. South America Particle Therapy Market, By System 2015–2025 (USD Million)
179. South America Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
180. South America Particle Therapy Market, By Application, 2015–2025 (USD Million)
181. Brazil Particle Therapy Market, By Type, 2015–2025 (USD Million)
182. Brazil Particle Therapy Market, By Product, 2015–2025 (USD Million)
183. Brazil Particle Therapy Market, By Services 2015–2025 (USD Million)
184. Brazil Particle Therapy Market, By System 2015–2025 (USD Million)
185. Brazil Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
186. Brazil Particle Therapy Market, By Application, 2015–2025 (USD Million)
187. Argentina Particle Therapy Market, By Type, 2015–2025 (USD Million)
188. Argentina Particle Therapy Market, By Product, 2015–2025 (USD Million)
189. Argentina Particle Therapy Market, By Services 2015–2025 (USD Million)
190. Argentina Particle Therapy Market, By System 2015–2025 (USD Million)
191. Argentina Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
192. Argentina Particle Therapy Market, By Application, 2015–2025 (USD Million)
193. Colombia Particle Therapy Market, By Type, 2015–2025 (USD Million)
194. Colombia Particle Therapy Market, By Product, 2015–2025 (USD Million)
195. Colombia Particle Therapy Market, By Services 2015–2025 (USD Million)
196. Colombia Particle Therapy Market, By System 2015–2025 (USD Million)
197. Colombia Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
198. Colombia Particle Therapy Market, By Application, 2015–2025 (USD Million)
199. Middle East and Africa Particle Therapy Market, By Type, 2015–2025 (USD Million)
200. Middle East and Africa Particle Therapy Market, By Product, 2015–2025 (USD Million)
201. Middle East and Africa Particle Therapy Market, By Services 2015–2025 (USD Million)
202. Middle East and Africa Particle Therapy Market, By System 2015–2025 (USD Million)
203. Middle East and Africa Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
204. Middle East and Africa Particle Therapy Market, By Application, 2015–2025 (USD Million)
205. Saudi Arabia Particle Therapy Market, By Type, 2015–2025 (USD Million)
206. Saudi Arabia Particle Therapy Market, By Product, 2015–2025 (USD Million)
207. Saudi Arabia Particle Therapy Market, By Services 2015–2025 (USD Million)
208. Saudi Arabia Particle Therapy Market, By System 2015–2025 (USD Million)
209. Saudi Arabia Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
210. Saudi Arabia Particle Therapy Market, By Application, 2015–2025 (USD Million)
211. UAE Particle Therapy Market, By Type, 2015–2025 (USD Million)
212. UAE Particle Therapy Market, By Product, 2015–2025 (USD Million)
213. UAE Particle Therapy Market, By Services 2015–2025 (USD Million)
214. UAE Particle Therapy Market, By System 2015–2025 (USD Million)
215. UAE Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
216. UAE Particle Therapy Market, By Application, 2015–2025 (USD Million)
217. Egypt Particle Therapy Market, By Type, 2015–2025 (USD Million)
218. Egypt Particle Therapy Market, By Product, 2015–2025 (USD Million)
219. Egypt Particle Therapy Market, By Services 2015–2025 (USD Million)
220. Egypt Particle Therapy Market, By System 2015–2025 (USD Million)
221. Egypt Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
222. Egypt Particle Therapy Market, By Application, 2015–2025 (USD Million)
223. Nigeria Particle Therapy Market, By Type, 2015–2025 (USD Million)
224. Nigeria Particle Therapy Market, By Product, 2015–2025 (USD Million)
225. Nigeria Particle Therapy Market, By Services 2015–2025 (USD Million)
226. Nigeria Particle Therapy Market, By System 2015–2025 (USD Million)
227. Nigeria Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
228. Nigeria Particle Therapy Market, By Application, 2015–2025 (USD Million)
229. South Africa Particle Therapy Market, By Type, 2015–2025 (USD Million)
230. South Africa Particle Therapy Market, By Product, 2015–2025 (USD Million)
231. South Africa Particle Therapy Market, By Services 2015–2025 (USD Million)
232. South Africa Particle Therapy Market, By System 2015–2025 (USD Million)
233. South Africa Particle Therapy Market, By Cancer Type, 2015–2025 (USD Million)
234. South Africa Particle Therapy Market, By Application, 2015–2025 (USD Million)

List of Figures
1. Global Particle Therapy Market Segmentation
2. Particle Therapy Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Particle Therapy Market attractiveness analysis by Type
9. Global Particle Therapy Market attractiveness analysis by Product
10. Global Particle Therapy Market attractiveness analysis by Service
11. Global Particle Therapy Market attractiveness analysis by System
12. Global Particle Therapy Market attractiveness analysis by Cancer Type
13. Global Particle Therapy Market attractiveness analysis by region
14. Global Particle Therapy Market: Dynamics
15. Global Particle Therapy Market Share by Types (2017 & 2025)
16. Global Particle Therapy Market Share by Products (2017 & 2025)
17. Global Particle Therapy Market Share by Service (2017 & 2025)
18. Global Particle Therapy Market Share by System (2017 & 2025)
19. Global Particle Therapy Market Share by Cancer Type (2017 & 2025)
20. Global Particle Therapy Market Share by Application (2017 & 2025)
21. Global Particle Therapy Market Share by Regions (2017 & 2025)
22. Global Particle Therapy Market Share by Company (2018)

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

Market research helps businesses strengthen a company’s position
Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
Market research helps in identifying the potential threats and opportunities associated with the business industry
Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

Data Collection
Data Synthesis
Market Deduction & Formulation
Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends.
Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information.

We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:

Export & Import Data
Business Information related to trade and its statistics
Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.

In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
Examining demographic along with psychographic segmentation for market evaluation
Analyzing the macro and micro-economic indicators for each demography
Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology.

Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.

The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample

Full Name

Country

Phone

Company

Designation

Comment

Human Verification

Our Clients

Choose License Type

For more information

Have a Question? Email us at

sales@fiormarkets.com

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Testimonials

Hi John,
Thanks for the report. We've been going through it and see some good data on the market and players. –

Kennedy Brown
Health Technology Innovation
United States

Hi Rahul,
Thank You for the report it is good and beneficial for me.
Thank You in Advance

Mika Salomäki

Dear Siddhartha,
Thank you for your fast reply. The report arrived safe and sound, evrything looks all right.
Thank you very much for your assitance and I will be looking forward to another opportunity for cooperation.

ONDŘEJ ŠUPKA
Analytics Department
ČESKÁ ZBROJOVKA A.S.

Dear Siddhartha,
The report looks good, and we believe the material mix is more realistic now. It is good to know you report “Net” Manufacturing Selling Price, as that can make a difference in how we view the numbers. The reports were great and we appreciate your working with us.
Thanks for all your help!